{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T19:16:24Z","timestamp":1794078984337,"version":"4.8.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T00:00:00Z","timestamp":1670716800000},"content-version":"am","delay-in-days":344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Government of Japan Ministry of Health Labour and Welfare","doi-asserted-by":"publisher","award":["21FC1006"],"award-info":[{"award-number":["21FC1006"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20ek0109474"],"award-info":[{"award-number":["JP20ek0109474"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21ek0109474"],"award-info":[{"award-number":["JP21ek0109474"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19ek0109259"],"award-info":[{"award-number":["JP19ek0109259"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jns.2021.120080","type":"journal-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:03:37Z","timestamp":1639181017000},"page":"120080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Characteristics of myotonic dystrophy patients in the national registry of Japan"],"prefix":"10.1016","volume":"432","author":[{"given":"Marika","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riho","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harumasa","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori P.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2021.120080_bb0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000369343","article-title":"Prevalence of muscular dystrophies: a systematic literature review","volume":"43","author":"Theadom","year":"2014","journal-title":"Neuroepidemiology."},{"key":"10.1016\/j.jns.2021.120080_bb0010","first-page":"594","article-title":"Myotonic dystrophies: an update on clinical aspects, genetic, pathology, and molecular pathomechanisms","volume":"2015","author":"Meola","year":"1852","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.jns.2021.120080_bb0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11910-002-0074-6","article-title":"Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2","volume":"2","author":"Ranum","year":"2002","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jns.2021.120080_bb0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/jhg.2011.152","article-title":"Myotonic dystrophy type 2 is rare in the Japanese population","volume":"57","author":"Matsuura","year":"2012","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.jns.2021.120080_bb0025","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1474-4422(12)70204-1","article-title":"The myotonic dystrophies: molecular, clinical, and therapeutic challenges","volume":"11","author":"Udd","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2021.120080_bb0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.gde.2017.01.007","article-title":"Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes","volume":"44","author":"Yum","year":"2017","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.jns.2021.120080_bb0035","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s13311-018-00679-z","article-title":"Myotonic dystrophies: targeting therapies for multisystem disease","volume":"15","author":"LoRusso","year":"2018","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.jns.2021.120080_bb0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/16501970500477967","article-title":"Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning","volume":"38","author":"Antonini","year":"2006","journal-title":"J. Rehabil. Med."},{"key":"10.1016\/j.jns.2021.120080_bb0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nmd.2009.03.007","article-title":"Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split?","volume":"19","author":"Laberge","year":"2009","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2021.120080_bb0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/mus.23478","article-title":"Fatigue and daytime sleepiness scale in myotonic dystrophy type 1","volume":"47","author":"Hermans","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2021.120080_bb0055","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/mus.26022","article-title":"Cognitive impairment and quality of life in patients with myotonic dystrophy type 1","volume":"57","author":"Fujino","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2021.120080_bb0060","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00415-017-8483-2","article-title":"The UK Myotonic dystrophy patient registry: facilitating and accelerating clinical research","volume":"264","author":"Wood","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.120080_bb0065","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.nmd.2009.08.009","article-title":"Patient registries and trial readiness in Myotonic dystrophy - TREAT-NMD\/Marigold International workshop report","volume":"19","author":"Thompson","year":"2009","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2021.120080_bb0070","first-page":"12","article-title":"Collaborating to bring new therapies to the patient - the TREAT-NMD model","volume":"28","author":"Bushby","year":"2009","journal-title":"Acta Myol."},{"key":"10.1016\/j.jns.2021.120080_bb0075","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00415-016-8132-1","article-title":"Design, set-up and utility of the UK facioscapulohumeral muscular dystrophy patient registry","volume":"263","author":"Evangelista","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.120080_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-8-60","article-title":"Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy)","volume":"8","author":"Nakamura","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2021.120080_bb0085","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13023-014-0150-4","article-title":"Nationwide patient registry for GNE myopathy in Japan","volume":"9","author":"Mori-Yoshimura","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2021.120080_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0148264","article-title":"Gender as a modifying factor influencing myotonic dystrophy type 1 phenotype severity and mortality: a nationwide multiple databases cross-sectional observational study","volume":"11","author":"Dogan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2021.120080_bb0095","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/355548a0","article-title":"Cloning of the essential myotonic dystrophy region and mapping of the putative defect","volume":"355","author":"Aslanidis","year":"1992","journal-title":"Nature."},{"key":"10.1016\/j.jns.2021.120080_bb0100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/cjn.2015.311","article-title":"A systematic review and Meta-analysis on the epidemiology of the muscular dystrophies","volume":"43","author":"Mah","year":"2015","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jns.2021.120080_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-018-0889-0","article-title":"Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease","volume":"13","author":"Wood","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2021.120080_bb0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3233\/JND-200538","article-title":"The Canadian neuromuscular disease registry 2010-2019: a decade of facilitating clinical research througha nationwide, pan-neuromuscular disease registry","volume":"8","author":"Hodgkinson","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2021.120080_bb0115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JND-170240","article-title":"The New Zealand neuromuscular disease patient registry; five years and a thousand patients","volume":"4","author":"Rodrigues","year":"2017","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2021.120080_bb0120","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ejhg.2011.23","article-title":"Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland","volume":"19","author":"Suominen","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.jns.2021.120080_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2018.00463","article-title":"Distribution and structure of DM2 repeat tract alleles in the German population","volume":"9","author":"Mahyera","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2021.120080_bb0130","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/WCO.0000000000000128","article-title":"Myotonic dystrophy: diagnosis, management and new therapies","volume":"27","author":"Turner","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jns.2021.120080_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104533","article-title":"Molecular genetics of congenital myotonic dystrophy","volume":"132","author":"Lanni","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2021.120080_bb0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/mus.26420","article-title":"The myotonic dystrophy experience: a north American cross-sectional study","volume":"59","author":"Hagerman","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2021.120080_bb0145","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1212\/WNL.0b013e318260cbe6","article-title":"Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1)","volume":"79","author":"Heatwole","year":"2012","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2021.120080_bb0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cortex.2017.08.008","article-title":"The cognitive profile of myotonic dystrophy type 1: a systematic review and meta-analysis","volume":"95","author":"Okkersen","year":"2017","journal-title":"Cortex."},{"key":"10.1016\/j.jns.2021.120080_bb0155","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1469-8749.2012.04379.x","article-title":"Psychiatric and cognitive phenotype of childhood myotonic dystrophy type 1","volume":"54","author":"Douniol","year":"2012","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.jns.2021.120080_bb0160","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/dmcn.12948","article-title":"Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy","volume":"58","author":"Johnson","year":"2016","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.jns.2021.120080_bb0165","doi-asserted-by":"crossref","first-page":"e852","DOI":"10.1212\/WNL.0000000000006948","article-title":"A large multicenter study of pediatric myotonic dystrophy type 1 for evidence-based management","volume":"92","author":"Lagrue","year":"2019","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2021.120080_bb0170","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1755-3768.2010.01956.x","article-title":"Ocular motor function in relation to gross motor function in congenital and childhood myotonic dystrophy type 1","volume":"90","author":"Aring","year":"2012","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jns.2021.120080_bb0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00415-013-7141-6","article-title":"Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1","volume":"261","author":"Kersten","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.120080_bb0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5105\/jse.11.Suppl1_133","article-title":"Human aging and ECG changes-mainly heart rate changes in healthy adults-JPN","volume":"11","author":"Yagi","year":"1991","journal-title":"J. Electrocardiol."},{"key":"10.1016\/j.jns.2021.120080_bb0185","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/clc.22737","article-title":"Population-based values and abnormalities of the electrocardiogram in the general Dutch population: the LifeLines cohort study","volume":"40","author":"van der Ende","year":"2017","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.jns.2021.120080_bb0190","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jns.2019.02.012","article-title":"Prevalence and predictor factors of respiratory impairment in a large cohort of patients with Myotonic dystrophy type 1 (DM1): a retrospective, cross sectional study","volume":"399","author":"Rossi","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2021.120080_bb0195","author":"Physical Fitness and Athletic Ability Survey: Japan Sports Agency"},{"key":"10.1016\/j.jns.2021.120080_bb0200","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/hmg\/ddz055","article-title":"Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes","volume":"28","author":"Overend","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jns.2021.120080_bb0205","first-page":"1","article-title":"Age and grip strength predict hand dexterity in adults","volume":"10","author":"Martin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2021.120080_bb0210","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.hlc.2016.01.015","article-title":"Association of age, sex, body size and ethnicity with electrocardiographic values in community-based older asian adults","volume":"25","author":"Tan","year":"2016","journal-title":"Hear. Lung Circ."},{"key":"10.1016\/j.jns.2021.120080_bb0215","first-page":"1","article-title":"The influence of aging on electrocardiographic findings in the population survey","volume":"5","author":"Saito","year":"2021","journal-title":"Jpn. J. Geriatr."},{"key":"10.1016\/j.jns.2021.120080_bb0220","series-title":"Prediction Equations for Normal and Low Lung Function from the Health Survey for England","first-page":"456","author":"Falaschetti","year":"2004"},{"key":"10.1016\/j.jns.2021.120080_bb0225","doi-asserted-by":"crossref","unstructured":"P. Medicine, P. Clinic, Lung Function in Healthy Never Smoking Adults: Reference Values and Lower Limits of Normal of a Swiss Population, (1996) 277\u2013283.","DOI":"10.1136\/thx.51.3.277"},{"key":"10.1016\/j.jns.2021.120080_bb0230","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/acn3.496","article-title":"Relationships between grip strength, myotonia, and CTG expansion in myotonic dystrophy type 1","volume":"4","author":"Hogrel","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jns.2021.120080_bb0235","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.nmd.2018.12.002","article-title":"Respiratory dysfunction in myotonic dystrophy type 1: a systematic review","volume":"29","author":"Hawkins","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2021.120080_bb0240","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1540-8167.2002.00444.x","article-title":"Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length","volume":"13","author":"Groh","year":"2002","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.jns.2021.120080_bb0245","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/mus.25468","article-title":"A review of muscle- and performance-based assessment instruments in DM1","volume":"56","author":"Symonds","year":"2017","journal-title":"Muscle Nerve"},{"issue":"2015","key":"10.1016\/j.jns.2021.120080_bb0250","first-page":"603","article-title":"Report of the second outcome measures in myotonic dystrophy type 1 (OMMYD-2) international workshop san Sebastian, Spain, October 16","volume":"25","author":"Gagnon","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2021.120080_bb0255","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00415-014-7570-x","article-title":"Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases","volume":"262","author":"Bouchard","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.120080_bb0260","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00415-018-8898-4","article-title":"A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1","volume":"265","author":"Gagnon","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.120080_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117511","article-title":"Metabolic complications in myotonic dystrophy type 1: a cross-sectional survey using the National Registry of Japan","volume":"427","author":"Hama","year":"2021","journal-title":"J. Neurol. Sci."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21027829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21027829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:29:07Z","timestamp":1777422547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X21027829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":53,"alternative-id":["S0022510X21027829"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.120080","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of myotonic dystrophy patients in the national registry of Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.120080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120080"}}